LMR Partners’s CME Group CME Stock Holding History

LMR Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,000	Closed	-$1.37M	–	1526
2025 Q4	$1.37M	Hold	5,000	–	–	﹤0.01%	908
2025 Q3	$1.35M	Buy	5,000 +2,000	+67%	+$544K	0.01%	846
2025 Q2	$827K	Buy	+3,000	New	+$816K	0.01%	839

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LMR Partners's CME Position: Q1 2026 in Review

LMR Partners sold out of CME Group (CME) in Q1 2026, closing a stake of 3 shares — an estimated $819 sold.

LMR Partners first reported a position in CME in Q2 2014 and held it in 19 quarters. The position peaked at $3.99M in Q4 2018. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

LMR Partners reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
LMR Partners sold 3 CME Group shares in Q1 2026, an estimated $819.
LMR Partners first reported a position in CME Group in Q2 2014 and held it in 19 quarters.
LMR Partners's CME Group position peaked at $3.99M in Q4 2018.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.